Company Profile

AvantBio Corporation
Profile last edited on: 12/31/20      CAGE: 598F5      UEI:

Business Identifier: Bioscience, biomedicine, and chemistry products
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2515 North East 104th Street
Vancouver, WA 98686
   (360) 433-8902
Location: Single
Congr. District: 03
County: Clark

Public Profile

AvantBio Corporation develops bioscience, biomedicine, and chemistry products and processes for therapeutic, bioresearch, and chemical reagent markets. The firm is developing new chemically defined animal-free supplements and basal media formulations for primary human epithelial and corneal cells used in wound healing, corneal transplant, and cosmetic applications. AvantFluor is commercializing novel sulfur fluorine intermediates based on its novel patent pending chemical processes.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2010 1 NIH $100,000
Project Title: Cutaneous Polyionic Therapeutics

Key People / Management

  Paul W Cook -- Co-founder, Chief Scientific and Executive Officer

  Corey Jacklin -- Chief Business Development Officer

  Rolf W Winter -- Co-founder, Vice President & Director of Chemistry R&D

Company News

There are no news available.